Benzinga's Top Initiations - Canadian Natural Res (NYSE:CNQ)

Analysts at Chardan Capital initiated coverage on

UniQure NVQURE

with a Buy rating. The target price for UniQure is set to $40. UniQure shares closed at $26.37 yesterday. Analysts at H.C. Wainwright initiated coverage on

DARA Biosciences IncDARA

with a Buy rating. The target price for DARA Biosciences is set to $2. DARA Biosciences' shares closed at $0.770 yesterday. Analysts at Nomura initiated coverage on

Coca-Cola Femsa, S.A.B. de C.V. (ADR)KOF

with a Neutral rating. The target price for Coca-Cola Femsa is set to $82. Coca-Cola Femsa shares closed at $78.68 yesterday. Maxim Group initiated coverage on

Radius Health IncRDUS

with a Buy rating. The target price for Radius Health is set to $50. Radius Health shares closed at $41.96 yesterday. Analysts at Roth Capital initiated coverage on

Juniper Pharmaceuticals IncJNP

with a Buy rating. The target price for Juniper Pharmaceuticals is set to $15. Juniper Pharmaceuticals' shares closed at $7.48 yesterday. Bank of America initiated coverage on

Boulder Brands IncBDBD

with a Neutral rating. The target price for Boulder Brands is set to $10.50. Boulder Brands' shares closed at $10.19 yesterday. Analysts at UBS initiated coverage on

Encana Corporation (USA)ECA

with a Buy rating. Encana's shares closed at $14.12 yesterday. UBS initiated coverage on

Canadian Natural Ltd (USA)CNQ

with a Buy rating. Canadian Natural shares closed at $33.63 yesterday.

Market News and Data brought to you by Benzinga APIs